MedTrace Logo

Real-world Clinical Benefit Evaluation in Breast Cancer Patients With Pharmaceutical Interventions for Cancer-related Fatigue

NCT05428527 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 261

Last updated 2024-07-03

No results posted yet for this study

Summary

This retrospective study is to collect and analyze the data from medical records within the period that breast cancer patient is receiving NHI-covered CRF treatment. This study will evaluate the clinical use, fatigue improvement, and treatment satisfaction of breast cancer patients with CRF treatment.

Conditions

  • Cancer-related Fatigue

Sponsors & Collaborators

  • Taichung Veterans General Hospital

    collaborator OTHER

  • E-Da Cancer Hospital

    collaborator UNKNOWN

  • Chang Gung Memorial Hospital, Taipei

    collaborator UNKNOWN

  • Chang Gung Memorial Hospital

    collaborator OTHER

  • Tri-Service General Hospital

    collaborator OTHER

  • China Medical University Hospital

    collaborator OTHER

  • Kaohsiung Medical University Chung-Ho Memorial Hospital

    collaborator OTHER

  • Mackay Memorial Hospital

    collaborator OTHER

  • Chang Gung Memorial Hospital, Keelung

    collaborator UNKNOWN

  • National Defense Medical Center, Taiwan

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-08
Primary Completion
2023-12-28
Completion
2023-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05428527 on ClinicalTrials.gov